arrow
J

J.K. Everett

pennsylvania medicine
H指数:33
被引数:5,706

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector Delivery

脑神经上皮瘤伴随AAV整合,经蛛网膜下腔大向量递送后

2026-05-0111
PRE
Hematopoietic Stem-Cell Gene Therapy for Cystinosis

半胱氨酸病的造血干细胞基因治疗

2026-02-195
PRE
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy

CD4 T细胞介导BCMA car-t细胞治疗后car-t细胞相关的免疫相关不良事件

2026-01-150
PRE
Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells

慢病毒载体用于造血干细胞基因治疗,可恢复α-地中海贫血红细胞中的α-球蛋白表达

2025-09-170
OAAI
Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence

非人灵长类动物中的组合CAR-T筛选识别出具有增强增殖、迁移和持久性的设计方案

Blood
IF23.1
2025-08-180
OA
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies

cGMP iPSC来源肌源性祖细胞产品的临床前质量、安全性和有效性研究,用于治疗肌营养不良。Mol. Ther.

2025-07-170
OAAI
Effective gene therapy for metachromatic leukodystrophy achieved with minimal lentiviral genomic integrations
2025-03-010
OAAI
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function
2024-11-150
OAAI
Dual-Vector-Transduction with Single-Step Magnetic Selection (Zip-sort) Increases Transgenic Payloads to Enhance CAR T Cell Activity

双向量转导结合单步磁选(Zip-sort)可增加转基因载荷以增强CAR T细胞活性

BLOOD
IF23.1
2024-11-050
PRE
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction
2023-04-0310
OA
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

自体T细胞治疗hla-a * 02患者的MAGE-A4实体癌: 1期试验

2023-01-0970
OAAI
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021

与2021夏季特拉华河谷疫苗突破相关的SARS-CoV-2变异

MBIO
IF4.7
2022-02-227
OAAI
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome
2022-01-2467
OAAI
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
2022-01-0328
OA